Bios 2024 Co-Invest, LP — SEC Form 4 filings
SEC reporting owner CIK 2028708. 1 Form 4 filing on record with FilingPulse; latest filed 2025-06-30.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2025-06-30 to 2025-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 71,428 shares, $499,996 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 71,428 shares @ $7.00 ($499,996) in ACTUATE THERAPEUTICS, INC., filed 2025-06-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director, 10% owner | 1 | 1 leg · 71,428 sh · $499,996 | — | 1 |
Form 4 filings — Bios 2024 Co-Invest, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-30 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Bios Equity COF, LP, Bios Clinical Opportunity Fund, LP, BP Directors, LP | Purchase (P): 71,428 @ $7 · Purchase (P): 71,428 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2028708 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →